AI-generated summary
The authors studied light therapy and riboflavin, alone and together, in a transgenic mouse model of familial ALS. They report no difference in survival between groups and no significant motor improvement except a rotarod gain in the light-only group early in disease, along with reduced astrocyte marker expression in the spinal cord after light therapy. The authors conclude the interventions were ineffective in altering disease progression.
- Who or what was studied
- G93A SOD1 transgenic mice modeling familial amyotrophic lateral sclerosis
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The study used an animal model and the abstract does not report a total sample size per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Mitochondria, Oxidative stress, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.